News
"Our results, based on 1.2 million Danish children and a study period covering 24 years, provide robust evidence supporting ...
A study of more than 1 million people found no link between aluminum in vaccines and an increased risk of autoimmune disease, allergies and autism.
Measles cases have climbed to their highest levels in 33 years, with outbreaks leading to deaths, hospitalizations, and ...
1h
LAist on MSNRise in measles cases worsens over summerMeasles cases in the U.S. have risen to the worst in 33 years, according to reports from the Centers for Disease Control and ...
Distrust of science is fueling such misguided proposals as scaling back critical public-health agencies.
2h
What to Expect on MSN7 Things to Know About Infant Vaccines Before Baby ArrivesAt baby's 2-month well visit, he'll receive a number of other essential immunizations, including RV (rotavirus), DTaP (diphtheria, tetanus and pertussis, which is also known as whooping cough), Hib ...
3h
The Mirror US on MSNMeasles signs and what to do as cases reach record high sparking new warningMeasles cases in the US have reached a new high, hitting the biggest numbers since the US eliminated the disease 25 years ago ...
Losing the status is a far bigger deal than most people likely know, and getting it back is no fast or easy feat.
North Dakota has reported its first case of measles in more than a month, just as the state hit a milestone that declared the ...
As measles cases surge across the country, health officials are urging families to stay current on vaccinations, warning that even small drops in community immunity can lead to dangerous outbreaks.
The FDA action comes weeks after US Health Secretary Robert F. Kennedy Jr said the government would no longer recommend the COVID vaccine for healthy children or pregnant people.
7h
Zacks Investment Research on MSNFDA Accepts GSK Filing for Expanded Use of RSV Shot in Younger AdultsGSK plc GSK announced that the FDA has accepted its regulatory filing seeking to expand the use of its RSV vaccine, Arexvy, in adults under 50 who are at a higher risk of the disease. A final decision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results